Skip to main content
. Author manuscript; available in PMC: 2010 Dec 10.
Published in final edited form as: Pharmaceuticals (Basel). 2010 Aug 1;3(8):2411–2469. doi: 10.3390/ph3082441

Table 1.

Class I/II and IV HDACs; cellular localization and cancer association

HDAC Localization Deregulation in cancer Tumor

Class I

HDAC1 Nucleus Overexpression/underexpression Esophageal, colon, prostate,
CTCL
HDAC2 Nucleus Overexpression/mutation Prostate, colon, gastric,
endometrial, CTCL
HDAC3 Nucleus Overexpression Prostate, colon
HDAC8 Nucleus Overexpression Colon

Class IIa

HDAC4 Nucleus/Cytoplasm Overexpression/underexpression/
mutation
Prostate, colon, breast
HDAC5 Nucleus/Cytoplasm Underexpression Colon, AML
HDAC7 Nucleus/Cytoplasm Overexpression Colon
HDAC9 Nucleus/Cytoplasm Overexpression/underexpression Medulloblastomas,
astrocytomas

Class IIb

HDAC6 Predominantly Cytoplasm Overexpression Breast, AML, CTCL
HDAC10 Predominantly Cytoplasm Overexpression Heptocellular Carcinoma

Class IV

HDAC11 Nucleus/Cytoplasm Overexpression Breast